A phase I/II study of intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy for localized nasal NK/T-cell lymphoma
Phase 1
- Conditions
- localized nasal NK/T-cell lymphoma
- Registration Number
- JPRN-UMIN000016795
- Lead Sponsor
- Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1) Clinical symptoms of Central nervous system involvement 2)Uncontrollable diabetes mellitus and/or hypertension 3) Uncontrollable myocardial infarction, angina, and/or cardiomyopathy 4) Positive test for HIV antibody 5) Interstitial pneumonia, pulmonary fibrosis or severe pulmonary emphysema 6) Severe infection 7) Liver cirrhosis 8) Other active malignancies 9) Pregnant, possible pregnant, or breastfeeding woman 10) Use of major tranquilizer, antidepressant, or antimanic 11) Severe psychosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method